Nomura Holdings
MBII

Nomura Holdings’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Nomura Holdings’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46,860
Closed -$33K – 2641
2021
Q4 		$33K Buy
+46,860
New +$37.9K ﹤0.01% 2091

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nomura Holdings's MBII Position: Q1 2022 in Review

Nomura Holdings sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 46,860 shares — an estimated $33K sold.

Nomura Holdings first reported a position in MBII in Q4 2021 and held it in 1 quarter. The position peaked at $33K in Q4 2021. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • Nomura Holdings reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • Nomura Holdings sold 46,860 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $33K.
  • Nomura Holdings first reported a position in Marrone Bio Innovations, Inc. in Q4 2021 and held it in 1 quarter.
  • Nomura Holdings's Marrone Bio Innovations, Inc. position peaked at $33K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.